Cargando…
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
BACKGROUND: Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal...
Autores principales: | Harris, Magdalena, Rhodes, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686576/ https://www.ncbi.nlm.nih.gov/pubmed/23651646 http://dx.doi.org/10.1186/1477-7517-10-7 |
Ejemplares similares
-
Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices
por: McGowan, Catherine, et al.
Publicado: (2013) -
The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs
por: Schatz, Eberhard, et al.
Publicado: (2016) -
A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK
por: Guise, Andy, et al.
Publicado: (2018) -
A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
por: Lazarus, Jeffrey V, et al.
Publicado: (2014) -
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
por: Mravčík, Viktor, et al.
Publicado: (2013)